IKBKG and fibrosarcoma: More specifically, we observed a 40–60% decrease in MCA205 WT fibrosarcoma growth (Fig. 3b and Supplementary Fig. S4b, left panels) and a 40% decrease in B16F10 WT melanoma growth (Fig. 3b and Supplementary Fig. S4b, right panels) upon treatment with IP2.